dopamine D2/norepinephrine transporter inhibitors (Astellas Pharma)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedopamine D2/norepinephrine transporter inhibitors (Astellas Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine transporter inhibitorsDopamine D2 receptor antagonists
TargetsNorepinephrine transporterDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A